By Daniella Parra Grove Collaborative Holdings, Inc. (NYSE: GROV) reported their Fourth Quarter Adjusted EBITDA of $0.1 million, positive for the second quarter in a row, and a record net revenue per order of $66.83. The sustainable consumer products company...

By Karen Roman a.k.a. Brands Holding Corp. (NYSE: AKA), a company that accelerates next generation fashion brands, announced its U.S. net sales grew 11.6% on the last quarter of 2023 and its total net sales decreased 0.1% to $148.9 million,...

By Daniella Parra Sparrow Pharmaceuticals continues its PROST! Phase 2 clinical trial for treating polymyalgia rheumatica (PMR) with SPI-62 and prednisolone, adding a fourth cohort, they said. PMR, an autoimmune disorder common among the elderly, traditionally treated with steroids like...

By Ambassador Marko Đurić Serbia has undergone a profound transformation over the past decade. Spearheaded by President Aleksandar Vučić’s vision of economic development and propelled by strategic reforms, our country’s economy has been booming as it charts a new course...

By Karen E. Roman Apollomics, Inc. (Nasdaq: APLM), a biopharmaceutical company that develops medicines for difficult-to-treat cancers, said it appointed Matthew Plunkett, Ph.D., as Chief Financial Officer. Dr. Plunkett has over 25 years of strategic and financial experience within the...

By Exec Edge Editorial Staff RBC Capital analyst Shagun Singh maintained Zynex, Inc. (Nasdaq:ZYXI) with an outperform rating and raised its price target from $13 to $15. Meanwhile, HC Wainwright & Co. analyst Yi Chen maintained a buy rating and...

By Daniella Parra FIGS, Inc. (NYSE: FIGS) said fourth quarter net revenue was $144.9 million and a reclassification negatively impacted net revenues by $4.7 million. Gross margin was 67.5%, a decrease of 70 basis points and operating expenses were $83.6...

By Daniella Parra Vivani Medical, Inc. (Nasdaq: VANI) reported promising preclinical data on NPM-115, a miniature exenatide implant for chronic weight management. The company focuses on GLP-1 implants for obesity treatment due to their potential to improve patient outcomes, which...

By Karen E. Roman Portillo’s Inc. (NASDAQ: PTLO), the casual restaurant known for its Chicago-style favorites menu, reported a 24.5% increase in total revenue for the last quarter of 2023 and a rise of 4.4% on same-restaurant sales. Operating income...

Exec Edge interviewed WHY Brands Inc. Founder and CEO Steven Dunn, Chief Brand Officer & Creative Officer Diana Barnes WHY has been transforming itself into a house of brands including Munchkin, Curio Dunn and Ms. Barnes co-founded lifestyle products company...